论文信息 - Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer - 字舞流文

Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer

Deena M. A. Gendoo | J. Haynes | Benjamin Haibe-Kains | A. Krešo | D. Jaffray | B. Wouters | U. Metser | Yadong Wang | T. McKee | D. Vines | Myles J. Smith | C. Leung | E. Szentgyorgyi | A. Haller | C. O’Brien | Robin Wolman | Evelyne Lima-Fernandes